187 results
Page 4 of 10
8-K
EX-10.1
dqz ahen9f
5 Aug 19
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-10.1
ma4 xytoszb7ln8rqgjc
24 Jul 19
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
agvstk2i vu8
28 May 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-10.1
1qzcy 3pg36
2 May 19
Entry into a Material Definitive Agreement
4:57pm
8-K
EX-10.1
1lhwrh2
12 Feb 19
Isoray Announces Second Quarter Fiscal 2019 Financial Results
4:13pm
8-K
EX-10.1
q9dz36fpv uv4dvsej9
17 Dec 18
IsoRay Announces the Appointment of
4:06pm
8-K
EX-10.1
2rdzqynh4twgru8kn6v
3 Dec 18
IsoRay Names Jonathan Hunt New Chief Financial Officer
4:56pm
8-K
EX-10.1
ikoud40y
12 Oct 18
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-10.2
236wnh4l4
25 Sep 18
IsoRay Announces Fourth Quarter and Full-Year 2018 Financial Results
4:02pm
8-K
EX-10.1
z4yvi 3q0
25 Sep 18
IsoRay Announces Fourth Quarter and Full-Year 2018 Financial Results
4:02pm
8-K
EX-10.2
28ma5cw xo9p4
11 Jul 18
IsoRay Announces FDA Clearance of GammaTile™ Therapy for the Treatment of Recurrent Brain Neoplasms
6:08am
8-K
EX-10.1
bpocpq
11 Jul 18
IsoRay Announces FDA Clearance of GammaTile™ Therapy for the Treatment of Recurrent Brain Neoplasms
6:08am
8-K
EX-10.3
99msqlj5y5uf s54o
11 Jul 18
IsoRay Announces FDA Clearance of GammaTile™ Therapy for the Treatment of Recurrent Brain Neoplasms
6:08am
8-K
EX-10.1
0mon2s3z
29 Jun 18
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.2
9n1ehdqnh czt31
19 Jun 18
IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO
4:35pm
8-K
EX-10.1
vdv9tqy8ig2y8
19 Jun 18
IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO
4:35pm
8-K
EX-10.1
s3zs4ypbf5 cz8iyq
21 May 18
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.2
kmnhff
21 May 18
Entry into a Material Definitive Agreement
8:33am